AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fourth Quarter and Fiscal Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Angiodynamics Inc (ANGO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 1,355,309 | $14,135,873 | +15% | 0% |
| 2. | Soleus Capital Guy Levy | 768,500 | $8,015,455 | +242% | 0.89% |
| 3. | Citadel Investment Group Ken Griffin | 539,222 | $5,624,085 | +28% | 0% |
| 4. | Tamarack Capital Management Justin John Ferayorni | 465,000 | $4,849,950 | -3% | 1.49% |
| 5. | Point72 Asset Management Steve Cohen | 435,954 | $4,547,004 | +281% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.82 | 1,083 | Officer | 89,581 | 2022-10-12 | Filing | |
| $15.00 | 10,000 | Officer, Director | 450,407 | 2022-10-10 | Filing | |
| $22.64 | 1,000 | Officer | 76,081 | 2022-01-12 | Filing | |
| $22.84 | 10,000 | Officer, Director | 390,764 | 2022-01-11 | Filing | |
| $9.38 | 1,013 | Officer | 60,273 | 2020-08-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.95 | 4,633 | Officer | 19,189 | 2023-01-31 | Filing | |
| $22.44 | 5,000 | Officer | 23,822 | 2022-07-29 | Filing | |
| $22.44 | 3,513 | Officer | 22,874 | 2022-04-28 | Filing | |
| $23.26 | 1,299 | Director | 79,704 | 2022-04-12 | Filing | |
| $23.00 | 6,201 | Director | 80,003 | 2022-04-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,385,401 | $77,029,733 | 0% | |
| 2. | 2,724,077 | $28,412,122 | 0% | |
| 3. | 2,123,170 | $22,145,156 | 0% | |
| 4. | 1,790,573 | $18,675,676 | 0% | |
| 5. | 1,438,438 | $15,002,908 | 0.01% |
News See All
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fiscal Year 2023 Third Quarter Earnings Call. At this time, all participants are in a listen-only mode.
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fiscal Year 2023 Second Quarter Earnings Call. At this time all participants are in listen-only-mode.
Where Do Hedge Funds Stand On AngioDynamics, Inc. (ANGO)?
We at Insider Monkey have gone over 867 13F filings that hedge funds and prominent investors are required to file by the SEC.
Should I Buy AngioDynamics, Inc. (ANGO)?
With the second-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the third ...
Is ANGO A Good Stock To Buy Now?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
Hedge Funds Never Been Less Bullish On AngioDynamics, Inc. (ANGO)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Do Hedge Funds Love AngioDynamics, Inc. (ANGO)?
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Is AngioDynamics, Inc. (ANGO) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is AngioDynamics, Inc. (ANGO) A Good Stock To Buy?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Billionaire Hedge Funds
